You are viewing the site in preview mode

Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis

Fig. 1

The flow diagram of experimental design. The iTRAQ was applied to identify the differentially expressed proteins in ER + breast cancer. Through bioinformatics analysis and in vitro studies, we found that ESF1 and MIPEP proteins are elevated in ER + breast cancer, promote tumor cell proliferation, and are associated with patient prognosis

Back to article page

Clinical Proteomics

ISSN: 1559-0275